The Natural History of Alpha-Mannosidosis

NCT00498420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2020-08-03

No results posted yet for this study

Summary

The natural history study of the rare lysosomal disease alpha-mannosidosis will answer the question; why the rare disease develops as it does?

Conditions

  • Alpha Mannosidosis

Sponsors & Collaborators

Principal Investigators

  • Michael Beck, MD · Children's Hospital, University of Mainz

  • Ed Wraith, MD · Willink Biochemical Genetics Unit, Royal Manchester Childern's Hospital

  • Jiri Zeman, MD · Department of Pediatrics, Charles University

  • Dag Malm, MD · Department of Medicine, University of Tromsoe

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-09-30
Completion
2009-11-30

Countries

  • Czechia
  • Germany
  • Norway
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00498420 on ClinicalTrials.gov